Participants are invited to submit abstracts for oral or poster presentations in the areas of pharmacy education and pharmacy research by 28 February 2022 [extended to 6 March 2022] via e-mail to firstname.lastname@example.org
Authors will be notified on the type of presentation by 28 March 2022.
Presenting author should be registered for the conference by 15 April 2022.
If you need any further information, please contact the Congress Secretariat (email@example.com).
Abstract Submission Guidelines:
All abstracts must be prepared according to the instructions below. Abstracts can not exceed 300 words and should not include any tables or figures. Abstracts which meet the Pharmacy Education Journal review criteria will be published in that journal.
Please note that you will receive an abstract receipt confirmation within 2 working days after submission. Should you not receive a confirmation, please contact the Conference Secretariat at firstname.lastname@example.org
THE COMPLETE TITLE SHOULD BE CAPITALISED, ON THE LEFT OF THE PAGE IN TIMES NEW ROMAN 14 POINT
Smith 1, D. Jones 1, R. Andrews 1,2
1 Royal Hospital, London, United Kingdom
2 University of New South Wales, Sydney, Australia
Authors: (Times New Roman, 10 point, left) Initials and Surnames for every author must be provided. Do not include degrees or titles. The name of the presenting author should be underlined. Include ORCID id for each author.
Affiliations: The affiliations should be typed under the list of authors’ names. Each author should be listed by institution, city, state/province and country. In abstracts where the authors have different affiliations, please indicate for each author the number of the corresponding affiliation – use superscripts.
Text: Abstract text must be in Calibri font, 12-point, single spacing and justified text. Abstract text should not exceed 300 words. No tables or figures should be included. Abbreviations should be kept to a minimum. Place abbreviations in parentheses after the full term for the first time it appears. Linguistic accuracy is the responsibility of the authors. Drug products mentioned in the abstract should be identified by their non-proprietary names only. Do not capitalise non-proprietary names.
Distribute the text in the following sections:
Literature References: Optional (list one or two maximum, according to Vancouver style). Must be included in 300-word limit.